InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by English Aron R., Director. Director active across 1 companies, notably Anebulo Pharmaceuticals, Inc.. Aggregated, 12 filings have been published. Total volume traded: €186k. The latest transaction was disclosed on 17 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
€2,324400 shares@ €5.81060.0% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-032220·
Ideal exit: 13 Sept 2022 (T+270)
€2,324400 shares@ €5.81060.0039% mcap0.0% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-032220:0·
Ideal exit: 13 Sept 2022 (T+270)
€2,152412 shares@ €5.22360.0% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-031664·
Ideal exit: 10 Sept 2022 (T+270)
€2,152412 shares@ €5.22360.0036% mcap0.0% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-031664:0·
Ideal exit: 10 Sept 2022 (T+270)
€23,6024,500 shares@ €5.24490.3% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-030513·
Ideal exit: 30 Aug 2022 (T+270)
€64,78313,836 shares@ €4.68220.8% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-030384·
Ideal exit: 29 Aug 2022 (T+270)
€23,6024,500 shares@ €5.24490.040% mcap0.1% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-030513:0·
Ideal exit: 30 Aug 2022 (T+270)
€64,78313,836 shares@ €4.68220.11% mcap0.4% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-030384:0·
Ideal exit: 29 Aug 2022 (T+270)
€4m714,250 shares@ €5.800249.4% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-012035·
€4m714,250 shares@ €5.80027.00% mcap24.7% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-012035:0·
€4m714,286 shares@ €5.800249.4% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-010808·
€4m714,286 shares@ €5.80027.00% mcap24.7% of flow
Common Stock, par value $0.001 per share
SEC:0001493152-21-010808:0·
12 of 12 declarations
About English Aron R.
English Aron R. serves as a Director at Anebulo Pharmaceuticals, Inc. As a director, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to provide valuable insights to board discussions. English Aron R. is committed to supporting innovation and sustainable growth within Anebulo Pharmaceuticals.
